Complete Up To Date Information about Dormosedan™.
NADA Number: 140-862 | |
| Proprietary Name |
Dormosedan™ |
|---|---|
| Sponsor |
Orion, Corp. |
| Sponsor Address |
Orionintie 1 Espoo, 02200 Finland |
| Ingredients |
Detomidine Hydrochloride |
| Species |
Horse, excluding breeding stock and not for food |
| Routes of Administration |
Intravenous Intramuscular |
| Dose Form |
Liquid (solution) |
| Drug Form |
Liquid (solution) |
| Dispensing Status |
RX |
| Patent Number |
4443466 4584383 |
| Exclusivity |
Granted for new Rx injectable for use as a sedative and analgesic to facilitate minor surgical and diagnostic procedures in mature horses and yearlings. |
|
Dosage Amount, Indications & Limitations |
522.536 Detomidine hydrochloride injection. Specifications: Each milliliter of sterile aqueous solution contains 10 milligrams of detomidine hydrochloride. Conditions of use: Horses (including yearlings) Amount: For sedation intravenously or intramuscularly, analgesia intravenously, or sedation and analgesia intravenously: 20 or 40 micrograms per kilogram (0.2 or 0.4 milliliter per 100 kilogram or 220 pounds) by body weight, depending on depth and duration required. Indication: As a sedative and analgesic to facilitate minor surgical and diagnostic procedures in mature horses and yearlings. Limitations: Do not use in horses with pre-existing atrioventricular or sinoauricular block, with severe coronary insufficiency, cerebrovascular disease, respiratory disease, or chronic renal failure. Do not use in breeding animals. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian. |